SEBI closes Religare case after Burman Group takeover
SEBI has closed proceedings against Religare Enterprises and former chair Rashmi Saluja, saying its earlier directions had served their purpose after the Burman Group completed its open offer and took control in February 2025.
What happened
SEBI closed proceedings against Religare and former chair Rashmi Saluja after Burman Group completed its open offer and assumed control in February 2025,
Key facts
- Open offer announced in September 2023
- Acquisition stake exceeded 25%
- Open offer for up to 26% of expanded voting share capital
- Control transferred in February 2025
- Post-offer advertisement issued February 18, 2025
Why this matters
SEBI’s closure of the proceedings confirms that the Burman Group’s open-offer takeover has cleared a key post-deal regulatory uncertainty.
What to watch
- Appointments or exits involving Religare's board, CEO and key subsidiary leadership.
- Burman Group disclosures on capital infusion, restructuring, stake changes or subsidiary strategy.
- Quarterly profitability, solvency and premium-growth trends at Care Health Insurance.
- Any new shareholder litigation, minority-investor objections or regulatory disclosures tied to past governance issues.
- Evidence of commercial partnerships or distribution synergies with Burman Group-affiliated businesses.
- Reconstitute Religare's board and senior leadership around Burman Group's operating strategy.
- Settle remaining legacy governance, compensation and related-party matters to remove residual reputational risk.
- Review capital needs and growth priorities at Care Health Insurance, Religare Broking and lending-related operations.
- Communicate a medium-term strategy for insurance distribution, digital financial services and possible group synergies.
- Prioritize retention of key executives, distribution partners and institutional relationships during the ownership transition.